The following was provided by the
Utah Division of Waste Management and Radiation Control (the Department) via email:
At 1000 MST, on 01/10/25, the Utah Cancer Specialists reported a medical event to the Department.
A patient was undergoing a Lutathera treatment (contains Lu-177). During treatment, the patient was to receive an amino acid infusion prior to the radiopharmaceutical administration, as per standard protocol. Initially, saline was started; however, the saline line remained clamped, preventing the amino acid infusion from commencing. Fifteen minutes after administering the radiopharmaceutical, it was observed that the amino acids had not been infused. Consequently, the Lutathera treatment was paused, the amino acid infusion was initiated, and subsequently, the Lutathera administration was completed.
The following additional information was obtained from the licensee in accordance with Headquarters Operations Officers Report Guidance:
The prescribed activity was 200 mCi of Lu-177 to the patient. The dose estimate, which is still being evaluated, falls under 10 CFR 35.3045 Subpart M.
Utah Event Report Number: UT250001
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.